Zykadia 150 mg (Ceritinib CAPSULE) 150 MG

ZYKADIA 150 MG capsules are a prescription medication used for specific therapeutic purposes. This oral treatment is manufactured by Novartis Pharmaceuticals Canada Inc. and is designed to target certain conditions.

Strength

150 MG

Pack Size

150

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ZYKADIA 150 MG capsules are primarily used in the management of certain types of cancer. This medication is often prescribed for patients who have specific genetic markers. The active ingredient, ceritinib, works by targeting abnormal proteins to help control the growth and spread of cancer cells. Patients should consult their healthcare provider to determine if this medication is suitable for their condition.

Side Effects

Common effects of ZYKADIA 150 MG capsules may include gastrointestinal issues such as nausea, vomiting, and diarrhea. Some patients may also experience fatigue, loss of appetite, and changes in blood sugar levels. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

Precautions & Warnings

ZYKADIA 150 MG capsules should be handled with care and stored as directed. Patients should avoid taking this medication if they are allergic to ceritinib or any of its components. It is crucial to follow the prescribed dosage and administration instructions provided by a healthcare provider. Regular monitoring may be necessary to manage potential side effects.

Avoid Interactions

ZYKADIA 150 MG capsules may interact with certain medications, including those that affect liver enzymes. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol and other substances that affect liver function should be avoided unless approved by a healthcare professional.

Frequently Asked Questions

ZYKADIA 150 MG capsules are used in the management of certain types of cancer, particularly those with specific genetic markers.

ZYKADIA 150 MG capsules are taken orally, typically once daily. Patients should follow the dosage and administration instructions provided by their healthcare provider.

Common side effects may include gastrointestinal issues such as nausea, vomiting, and diarrhea, as well as fatigue and changes in blood sugar levels.

Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Patients should avoid taking ZYKADIA 150 MG if they are allergic to ceritinib and follow the prescribed dosage and administration instructions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.